Skip to main content
Caplight Logo









Ziphius Vaccines

Ziphius Vaccines

Private
BelgiumHealthcare & Life Scienceshttps://ziphius.org

Company Overview

Ziphius Vaccines operates in Healthcare & Life Sciences and is based in Belgium. It was founded in 2019.

Ziphius Vaccines is a biopharmaceutical company that develops a self-amplifying RNA (saRNA) platform for vaccines and therapeutics to prevent infectious diseases and for protein enhancement therapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ziphius Vaccines Comparables

Compare Ziphius Vaccines with similar companies based on industry and business-model similarity.

Ziphius Vaccines comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Immorna
88%
Replicate Bioscience
85%
Chimeron Bio
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ziphius Vaccines Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Ziphius Vaccines. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Ziphius Vaccines Filings

Explore SEC and related filing metadata, where available.

Ziphius Vaccines filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ziphius Vaccines's valuation, stock price, and market status.

Is Ziphius Vaccines a public or private company?

Ziphius Vaccines is a private company.

What is the current stock price of Ziphius Vaccines?

Ziphius Vaccines is a private company, so its shares have no public market price. Caplight tracks Ziphius Vaccines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ziphius Vaccines worth (valuation)?

Valuation information for Ziphius Vaccines is not publicly available.

Can I buy Ziphius Vaccines stock?

Ziphius Vaccines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ziphius Vaccines's last funding round?

Funding round information for Ziphius Vaccines is not publicly available.

Who are the main investors in Ziphius Vaccines?

Investor information for Ziphius Vaccines is not publicly disclosed.

Will Ziphius Vaccines IPO soon?

No public IPO plans have been announced for Ziphius Vaccines.

How can I track Ziphius Vaccines secondary market activity?

Caplight tracks bids, offers, and trades in Ziphius Vaccines's shares on secondary markets.

Firmographic Details

HeadquartersBelgium
Year Founded2019
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?